[go: up one dir, main page]

US20190338238A1 - Perfusion Bioreactor With Filtration Systems - Google Patents

Perfusion Bioreactor With Filtration Systems Download PDF

Info

Publication number
US20190338238A1
US20190338238A1 US16/403,161 US201916403161A US2019338238A1 US 20190338238 A1 US20190338238 A1 US 20190338238A1 US 201916403161 A US201916403161 A US 201916403161A US 2019338238 A1 US2019338238 A1 US 2019338238A1
Authority
US
United States
Prior art keywords
filtration system
filtration
liquid media
cell culture
culture apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/403,161
Other languages
English (en)
Inventor
Jiuyi LU
Jason Walther
Jonathan Wang
Kevin Victor Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority to US16/403,161 priority Critical patent/US20190338238A1/en
Assigned to GENZYME CORPORATION reassignment GENZYME CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WALTHER, JASON, CHEN, KEVIN VICTOR, LU, Jiuyi, WANG, JONATHAN
Publication of US20190338238A1 publication Critical patent/US20190338238A1/en
Priority to US17/524,269 priority patent/US11434464B2/en
Priority to US18/308,870 priority patent/US12110483B2/en
Priority to US18/823,894 priority patent/US20250027031A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1807—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using counter-currents, e.g. fluidised beds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/18—Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/22—Controlling or regulating
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/12—Pulsatile flow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/44—Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10—Separation or concentration of fermentation products
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2626—Absorption or adsorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2688—Biological processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2313/00—Details relating to membrane modules or apparatus
    • B01D2313/24—Specific pressurizing or depressurizing means
    • B01D2313/243—Pumps
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/10—Cross-flow filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2317/00—Membrane module arrangements within a plant or an apparatus
    • B01D2317/04—Elements in parallel
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2317/00—Membrane module arrangements within a plant or an apparatus
    • B01D2317/06—Use of membrane modules of the same kind

Definitions

  • the disclosure relates generally to a perfusion cell culture apparatus and a method of cell culture.
  • In vitro cell culture is the complex process by which cells are grown under controlled conditions outside of their natural environment. Culture conditions may vary for each cell type, and must be precisely controlled to ensure the correct cell phenotype and/or expression of a desired product.
  • Bioreactors provide a controlled environment to grow and maintain cells according to their temperature, pH, nutrition, gas, and other needs. In order to culture cells for an extended period of time, fresh media must be continuously supplied to the cells, and spent media must be removed at approximately the same rate. To extend the productive duration of cell culture within a bioreactor, perfusion bioreactors have been developed which continuously perfuse cells with fresh media, and harvest a desired product while retaining cells in the bioreactor. Such bioreactors have allowed cells to be grown at higher cell concentrations and maintained for extended periods of time relative to bioreactors without active perfusion systems.
  • FIG. 1 shows a schematic of a typical state-of-the-art perfusion bioreactor 100 , as is known by those familiar with the field.
  • the perfusion bioreactor includes a bioreactor vessel 110 , an alternating tangential flow (ATF) filter 120 , a harvest pump 130 , and a continuous capture operation 160 .
  • the perfusion bioreactor 100 can be operated by (i) attaching an ATF filter device 120 to the bioreactor vessel 110 ; (ii) filling the bioreactor vessel 110 with fresh media; (iii) inoculating the bioreactor vessel 110 with cells; and (iv) perfusing fresh media into the bioreactor vessel 110 and removing spent media via the harvest pump 130 in series with the ATF filter 120 .
  • cells may be cultured and maintained for an extended period of time.
  • the continually added media gives the cells the nutrients they require to grow, and the removed spent media allows cellular wastes and byproducts to be removed from the system to prevent them from reaching harmful levels.
  • the ATF filter allows spent media to be removed from the bioreactor while retaining the cells within the bioreactor.
  • Other cell culture parameters are typically also controlled to improve performance and robustness, including temperature, dissolved oxygen, pH, pCO 2 , and cell density.
  • the perfusion bioreactor 100 can be integrated with a continuously operating capture operation 160 .
  • the spent media being removed from the bioreactor vessel 110 contains the product of interest and is continuously fed to the continuous capture operation 160 where it is processed and purified in some manner.
  • a standard perfusion bioreactor such as the bioreactor shown in FIG. 1
  • the ATF filter can fail, leading to process disruption or perturbation.
  • the ATF filter can fail catastrophically such that it allows cells to pass through the filter and into the harvest.
  • Such an incident can have a variety of negative impacts.
  • cells could pass onto the columns on a periodic continuous counter-chromatography (PCC) skid, leading to clogging, pressurization, and increased introduction of impurities.
  • PCC periodic continuous counter-chromatography
  • the problem must be quickly identified and the ATF must be quickly replaced to preserve the bioreactor.
  • the downstream operation would likely need to be shut down and cleaned, and single-use parts may need to be replaced.
  • the entire response could lead to days of lost production and, at worst, lead to an entire run shutdown.
  • An apparatus and method for cell cultivation that overcomes one or more of the disadvantages known in the art is provided. It has been found that it is possible to prepare a filtration system for a perfusion cell culture apparatus that automatically detects and responds to an ATF filter malfunction, without the need to shut down the cell culture operation.
  • a perfusion cell culture apparatus in a first embodiment of the disclosure, includes a bioreactor vessel, a first filtration assembly, a second filtration assembly, and a controller.
  • the bioreactor vessel is configured to receive liquid media.
  • the first filtration assembly is in fluid communication with the bioreactor vessel and includes a first filtration system, a first harvest pump, and a sensor.
  • the first harvest pump is connected in series with the first filtration system and is configured to pump the liquid media from the bioreactor vessel through the first filtration system.
  • the sensor is configured to interact with the liquid media inside the first filtration assembly.
  • the second filtration assembly is also in fluid communication with the bioreactor vessel and is configured to operate in parallel with the first filtration assembly.
  • the second filtration assembly includes a second filtration system and a second harvest pump.
  • the second harvest pump is connected in series with the second filtration system and is configured to pump the liquid media from the bioreactor vessel through the second filtration system.
  • the controller executes operations.
  • the operations include receiving, from the sensor, information indicative of an operational state of the first filtration system.
  • the operations further include determining, based on at least the received information, whether the first filtration system is in an operable state.
  • the operations also include, responsive to a determination that the first filtration system is not in an operable state, causing the first harvest pump to stop pumping liquid media through the first filtration system.
  • a perfusion cell culture apparatus in a second embodiment of the disclosure, includes a bioreactor vessel, a filtration assembly, and a controller.
  • the bioreactor vessel is configured to receive liquid media.
  • the filtration assembly is in fluid communication with the bioreactor vessel and includes a filtration system, a harvest pump, and a sensor.
  • the harvest pump is connected in series with the filtration system and is configured to pump the liquid media from the bioreactor vessel through the filtration system.
  • the sensor is configured to interact with the liquid media inside the filtration assembly.
  • the controller executes operations.
  • the operations include receiving, from the sensor, information indicative of an operational state of the filtration system.
  • the operations further include determining, based on at least the received information, whether the filtration system is in an operable state.
  • the operations further include, responsive to a determination that the tangential flow is not in an operable state, causing the harvest pump to stop pumping liquid media through the filtration system.
  • a method in yet another embodiment of the disclosure, includes at least partially filling a bioreactor vessel with cells and liquid media.
  • the bioreactor vessel is in fluid communication with a first filtration system and a second filtration system.
  • the second filtration system is connected in parallel with the first filtration system.
  • the method further includes pumping liquid media from the bioreactor vessel through the first filtration system using a first harvest pump.
  • the first harvest pump is connected in series with the first filtration system.
  • the method also includes pumping liquid media from the bioreactor vessel through the second filtration system using a second harvest pump.
  • the second harvest pump is connected in series with the first filtration system.
  • the method additionally includes receiving, from a sensor configured to interact with the liquid media, information indicative of an operational state of the first filtration system.
  • the method includes determining, based on at least the received information, whether the first filtration system is in an operable state. Still further, the method includes, responsive to a determination that the first filtration system is not in an operable state, causing the first harvest pump to stop pumping liquid media through the first filtration system.
  • FIG. 1 shows a schematic of a standard perfusion bioreactor setup.
  • FIG. 2 shows a schematic of a perfusion cell culture apparatus with dual filtration systems and integrated capture according to one embodiment of the disclosure.
  • FIG. 3 shows a schematic of a perfusion cell culture apparatus with dual filtration systems and integrated capture according to another embodiment of the disclosure.
  • FIG. 4 shows a schematic of a perfusion cell culture apparatus setup with a single filtration system according to another embodiment of the disclosure.
  • FIG. 5 shows a flowchart of a method according to an embodiment of the disclosure.
  • the perfusion cell culture apparatus of the disclosure comprises a bioreactor vessel and two or more filtration systems (e.g., alternating tangential flow filters) connected in parallel.
  • a failure in either filter may be detected by an in-line sensor, and an automated response system functions to sequester the malfunctioning filter by stopping the flow of liquid media through the filter.
  • Media flow through the remaining operable filters can be increased so that the rate of perfusion through the bioreactor remains relatively unchanged.
  • the cell culture apparatus of the disclosure may prevent issues that arise from filter failures in conventional perfusion bioreactors, thereby improving the long-term viability of cell cultures.
  • a cell culture apparatus that automatically detects and responds to a filtration system failure.
  • a cell culture apparatus could include built-in redundancy, such that a second and/or further filtration system can be used if and when a first filter fails (e.g., by rupturing, clogging, fouling, or some other means).
  • an automated response system may function to stop media flow to the affected filter, while increasing throughput through any remaining filters. This response may allow perfusion of liquid media to continue at approximately the same rate, without the need for immediate intervention by an operator of the cell culture apparatus.
  • Such a system may improve cell viability and reduce the chance of failure in perfusion bioreactor systems.
  • the apparatus and methods of the present disclosure generally relate to a perfusion cell culture apparatus with an improved tangential flow filtration system.
  • the apparatus may include a bioreactor vessel configured to house a cell population and liquid growth media. Fresh liquid media may be provided to the bioreactor vessel, and spent liquid media may be removed at an approximately equal rate through a series of filtration assemblies.
  • Each filtration assembly may include a filtration system, a harvest pump, a sensor, and/or a guard filter.
  • spent liquid media is removed through one or more of the filtration assemblies and pumped into a downstream capture operation.
  • Sensors provided in each filtration assembly may continuously monitor the operation of the filtration assemblies, and determine when a malfunction (e.g., a rupture, a clog, or some other failure mode) occurs in one of the filtration systems.
  • an automated response system acts to change the operating parameters of the apparatus so that perfusion of liquid media continues without interruption.
  • the automated response system is carried out by a controller in communication with a sensor and harvest pump. Responsive to determining that one or more of the filtration systems is not in an operable state, the controller may cause a harvest pump associated with the inoperable filter to cease pumping liquid media to the affected filter. Additionally, the controller may cause the remaining operable filtration assembly to process an increased amount of liquid media, e.g., by causing the associated harvest pump to increase liquid media flow to the operable filtration system. The controller may also cause the apparatus to output a notification, for instance, an alarm, an indicator light, or some other alert.
  • the controller may also shut down the filtration system (e.g., by causing a tangential flow pump of the filtration system to stop pumping liquid media across a filter membrane.) In some scenarios, the controller may also stop a downstream capture operation or actuate vales to stop liquid media flow and/or divert liquid media to a waste container. In still another scenario, the controller may completely shut down flows in and out of the bioreactor vessel if a bioreactor sensor (e.g., capacitance, optical density, oxygen uptake rate, etc.) drops below a certain threshold. Other automated responses are also contemplated.
  • a bioreactor sensor e.g., capacitance, optical density, oxygen uptake rate, etc.
  • the cell culture apparatus 200 includes a bioreactor vessel 210 , a continuous capture operation 260 , and at least a first filtration assembly 206 and second filtration assembly 208 connected in parallel between at least one outlet of the bioreactor vessel 210 and an inlet of the continuous capture operation 260 .
  • the bioreactor vessel 210 of the cell culture apparatus 200 is configured to receive fresh liquid media in order to maintain the cell population within the vessel.
  • liquid media may refer to a nutritional growth medium or culture medium designed to support the growth of cells.
  • a bioreactor sensor 215 may be positioned so that it interacts with liquid media inside the bioreactor vessel 210 .
  • Such a bioreactor sensor 215 could be configured to measure a temperature, dissolved oxygen, pH, pCO 2 , and/or cell density of the bioreactor vessel 210 and/or liquid media inside the bioreactor vessel 210 .
  • the cell culture apparatus 200 may be integrated with a continuously operating capture operation 260 that is configured to collect product (e.g., a desired biologic or therapeutic product) from the liquid media.
  • the capture operation 260 is in fluid communication with the bioreactor vessel 210 by way of at least the first filtration assembly 206 .
  • the capture operation 260 may receive spent liquid media after it passes through the parallel filtration assemblies 206 , 208 and process and/or purify the media to harvest a desired product of interest.
  • the capture operation 260 could employ a variety of techniques to harvest the product of interest.
  • the capture operation 260 could include a continuous chromatography system including one or more chromatography columns.
  • the capture operations 260 could include a periodic continuous counter-chromatography (PCC) skid, or a simulated moving bed (SMB) skid.
  • the capture operation 260 could include a multi-chromatography (MCC) skid (i.e., a continuous chromatography system including multiple columns).
  • MCC multi-chromatography
  • a first filtration assembly 206 includes a first filtration system 220 , a first harvest pump 230 , a first sensor 240 , and a first guard filter 250 .
  • a second filtration assembly 208 includes a second filtration system 222 , a second harvest pump 232 , a second sensor 242 , and a second guard filter 252 .
  • the elements of each filtration assembly 206 , 208 may be connected in series via one or more conduits, sterile tubing, or another connection means.
  • the first harvest pump 232 may be connected downstream of the first filtration system 220
  • the sensor 240 may be located downstream of the first harvest pump 230 , disposed between the first harvest pump 230 and a guard filter 250 connected yet further downstream.
  • downstream refers to a relative location or orientation of an element relative to the flow of liquid media through the filtration assemblies 206 , 208 , where “downstream” refers generally to the direction toward the capture operation 260 and away from the bioreactor vessel 210 .
  • elements of the first filtration assembly 206 may be connected in any number of configurations.
  • a second filtration assembly 208 and/or further filtration assembly may be arranged with elements in substantially the same configuration as the first filtration assembly 206 , or in a different configuration entirely.
  • a second filtration assembly 208 is configured to operate in parallel (i.e., simultaneously) with the first filtration assembly 206 .
  • the flow rate of liquid media through the first filtration assembly 206 and second filtration assembly 208 could be approximately equal.
  • each filtration assembly 206 , 208 may receive an approximately equal flow rate of spent liquid media from the bioreactor vessel 210 .
  • a single filtration assembly e.g., the first filtration assembly 206
  • second filtration assembly 208 and/or further filtration assembly may operate as backup.
  • a third or further filtration assembly may be connected in parallel with the first filtration assembly 206 and second filtration assembly 208 in order to increase throughput, provide an additional backup filtration means in case of a system failure, or provide some other benefit.
  • the first filtration assembly 206 and the second filtration assembly 208 include a first filtration system 240 and a second filtration system 242 , respectively.
  • the first and second filtration systems 220 , 222 may be configured to prevent cells in the bioreactor vessel 210 from entering the continuous capture operation 260 , while allowing the free passage of cellular wastes and one or more desired products of interest.
  • the term “filtration system” is used to refer to a filter-based means for retaining cells within the bioreactor vessel 210 .
  • the first filtration system 220 and the second filtration system 222 could include filters that function by flowing a fluid (e.g., the liquid media) tangentially across a filter membrane.
  • Such a filtration system 220 , 222 could include conventional tangential flow filtration (TFF) systems, cross-flow filters, and similar cell retention means.
  • at least one of the first filtration system 220 and the second filtration system 222 include alternating tangential flow (ATF) filters.
  • filters typically include a filter membrane and a tangential flow pump (e.g., a diaphragm pump) configured to direct fluid tangentially across the filter membrane.
  • the tangential flow pump may include a diaphragm that is actuated to flow liquid media from the bioreactor vessel 210 across the surface of the filter membrane in a repeated back and forth pattern.
  • a first tangential flow pump provided by the first filtration system may be operated independently from a second tangential flow pump provided by the second filtration system.
  • the two or more tangential flow pumps may be controlled in a unified way, such that their pumping action is entirely synchronized or anti-synchronized.
  • first filtration assembly 206 and the second filtration assembly 208 have insofar been described as including ATFs or other tangential flow-based filters, other filtration means may be implemented to retain cells in the bioreactor vessel 210 .
  • first filtration system 220 and the second filtration system 222 could include internal spin filters (ISF), hollow fiber filters, porous membrane filters, depth filters, and/or other microfiltration or ultrafiltration systems.
  • ISF internal spin filters
  • hollow fiber filters porous membrane filters
  • depth filters and/or other microfiltration or ultrafiltration systems.
  • the first filtration system 220 and the second filtration system 222 include a first filter membrane and a second filter membrane, respectively.
  • the pore size of the filter membranes may be selected such that a desired product of interest, cellular waste, and spent liquid media are free to flow through the membrane, while cells are retained within the bioreactor vessel 210 .
  • the filter membrane of filtration systems 220 , 222 may be made up of any material with a suitable pore size, for instance, a porous polymeric membrane.
  • the filter membrane is comprised of a series of selectively permeable hollow fibers organized in a parallel array inside of a housing or cartridge.
  • the pore size of the hollow fiber membrane may be selected to achieve the desired permeability of the filtration systems 220 , 222 .
  • each of the first filtration system 220 and the second filtration system 222 include a pore size ranging from about 500 kiloDaltons to about 10 microns, or more preferably between about 0.1 micron and about 1 micron.
  • Each filtration assembly 206 , 208 includes a harvest pump 230 .
  • the first filtration assembly 206 includes a first harvest pump 230 connected in series with the first filtration system 220 .
  • the second filtration assembly 208 includes a second harvest pump 232 connected in series with the second filtration system 222 .
  • the first harvest pump 230 and second harvest pump 232 are configured to pump liquid media from the bioreactor vessel 210 through the first filtration system 220 and the second filtration system 222 , respectively, and into the downstream capture operation 260 .
  • the first harvest pump 230 and/or the second harvest pump 232 could include peristaltic pumps, bearingless pumps, diaphragm pumps, or centrifugal pumps. However, other pumps may be used which maintain sterility of the liquid media while pulling the media through the filtration assemblies 206 , 208 .
  • the first harvest pump 230 pumps liquid media from the bioreactor vessel 210 through the first filtration system 220 at a first flow rate.
  • the second harvest pump 232 likewise pumps liquid media from the bioreactor vessel 210 through the second filtration system 222 at a second flow rate.
  • the first flow rate could be approximately equal to the second flow rate.
  • the first harvest pump 230 and the second harvest pump 232 may be configured to pump an approximately equal amount of liquid media through their respective filtration systems 220 , 222 , such that the filtration assemblies process an equal amount of spent liquid media under normal operating conditions.
  • the first flow rate and the second flow rate may be different.
  • the first harvest pump 230 may operate alone and independently, while the second harvest pump 232 (i.e., a second or further harvest pump connected to a second or further filtration apparatus) may be configured to operate responsive to a determination that the first harvest pump 230 , the first filtration system 220 , and/or the first filtration assembly 206 is not in an operable state.
  • the second harvest pump 232 i.e., a second or further harvest pump connected to a second or further filtration apparatus
  • the flow rate of liquid media through the filtration assemblies 206 , 208 may be approximately equal to a flow rate of fresh media into the bioreactor vessel 210 such that a steady amount of liquid media is maintained in the vessel 210 during perfusion.
  • the sum of the first flow rate and the second flow rate could be approximately equal to a flow rate of liquid media into the bioreactor vessel 210 (i.e., the flow rate of media introduced to the vessel 210 by a feed operation).
  • the flow rate of liquid media through each filtration system 220 , 222 may be controlled independently by a controller 270 in communication with the first harvest pump 230 and the second harvest pump 232 .
  • the controller 270 may be configured to cause the first harvest pump 230 and/or second harvest pump 232 to increase, decrease, or stop the flow of liquid media through the first filtration system 240 and/or second filtration system 242 depending on the operating conditions of the apparatus 200 . For instance, upon failure of one or more of the filtration systems 220 , 222 , the harvest pump of the affected assembly may be turned off, while the flow rate of liquid media through a remaining filtration assembly could be increased to compensate for the malfunctioning filtration assembly.
  • filtration systems 220 , 222 may be prone to malfunction, potentially leading to problems in the downstream capture operation 260 , increased impurities in the harvest, and in some cases an entire run shutdown.
  • a guard filter 250 , 252 may be connected in series with the first filtration system 220 and/or second filtration system 222 . Such a guard filter 250 , 252 could be configured to prevent cells and cell debris from passing downstream to the capture operation 260 , while freely allowing the diffusion of nutrients, metabolic products, and liquid media. As illustrated in FIG.
  • a guard filter 250 could be connected in series with the first filtration system 220 and/or the first filtration assembly 206 .
  • the guard filter 250 is connected downstream of the first filtration system 220 and/or the sensor 240 .
  • the second filtration assembly 208 may also include a guard filter (i.e., a second guard filter 252 ) connected in series with the second filtration system 222 downstream of the filtration system 222 .
  • a guard filter i.e., a second guard filter 252
  • multiple filtration assemblies may converge on a single shared guard filter located e.g., at an inlet of the continuous capture operation 260 .
  • Other locations and configurations of a guard filter 250 are envisioned.
  • Guard filters 250 , 252 may be made up of any material with suitable porosity, for instance, a porous polymer membrane and/or a hollow fiber membrane.
  • the guard filter 250 includes a pore size of about 500 kiloDaltons to about 10 microns, or more preferably from about 0.1 micron to about 1 micron.
  • the guard filter 250 may be configured with a pore size that is approximately equal to the pore size of the first filtration system 220 and/or second filtration system 222 (i.e., so as to mimic the selective permeability of filtration systems 220 , 222 ).
  • the guard filter 250 could comprise a smaller or larger pore size than the filtration systems 220 , 222 , thereby allowing for the selective filtering of additional metabolic products.
  • At least one sensor 240 may be provided within a filtration assembly 206 , 208 to monitor operation of the one or more filtration systems 220 , 222 and/or detect a filter failure.
  • the first filtration assembly 206 may include a sensor 240 .
  • the second filtration assembly 208 may include a further sensor (e.g., second sensor 242 ).
  • the sensor 240 could be positioned along a conduit of a filtration assembly 206 , 208 and could be configured to interact with the liquid media in the filtration assembly 206 , 208 , i.e., so as to detect various aspects of the liquid media passing through the filtration assembly 206 , 208 . As shown in FIG.
  • a sensor 240 could be disposed downstream of the first filtration system 220 and upstream of the guard filter 250 .
  • the sensor 240 could include a pressure sensor, or, more particularly, a piezoresistive pressure sensor.
  • the sensor 240 could be configured to detect a pressure in the first filtration assembly 206 (e.g., a pressure of the liquid media inside the first filtration assembly 206 ), which may be indicative of a clogged guard filter 250 and/or a rupture in the upstream first filtration system 220 .
  • the senor 240 could be configured to detect a pressure upstream or downstream of the first guard filter 250 , a pressure upstream or downstream of the first filtration system 220 , and/or a transmembrane pressure across the first filtration system 220 or guard filter 250 .
  • the sensor 240 could be an optical sensor (e.g., an optical density probe), and the sensor 240 could be configured to determine a cell density in the liquid media flowing through the first filtration assembly 206 .
  • the sensor 240 could include a flow meter operable to measure a flow rate of liquid media through the filtration systems 220 , 222 and/or filtration assemblies 206 , 208 .
  • the senor 240 may include a capacitance sensor, a Raman sensor, or an FTIR (Fourier transform infrared) sensor.
  • the sensor 240 could be integrated into the continuous capture operations (e.g., as a pressure sensor upstream of the capture column). Other sensor types and applications are envisioned.
  • sensors 240 , 242 in FIG. 2 are illustrated as being included in the first filtration assembly 206 and second filtration assembly 208 (i.e., disposed in a conduit between the filtration systems 220 , 222 and the guard filters 250 , 252 ), sensors could be disposed in a variety of locations.
  • a bioreactor sensor 215 could be configured to interact with liquid media in the bioreactor vessel 210 , such that the bioreactor sensor 215 can monitor changes in pressure, temperature, pH, dissolved oxygen, pCO 2 , cell density, or other characteristics of the liquid media inside the vessel 210 .
  • the cell culture apparatus 200 could include an automated response system.
  • the response system may be used to detect a filtration system failure (e.g., a rupture of the filter membrane), sequester the malfunctioning filtration system, and/or adjust operating parameters of the apparatus 200 in order to continue cell perfusion relatively unchanged.
  • the automated response system may be implemented by a controller 270 in communication with at least the harvest pumps 230 , 232 and the sensors 240 , 242 .
  • the controller 270 could include at least one processor configured to execute operations (e.g., operations stored as program instructions in a data storage of the controller).
  • the controller 270 could include a comparator or another simplified control system.
  • the controller 270 may be configured to receive, from the sensors 240 , 242 , information indicative of an operational state of the first filtration system 220 and/or second filtration system 222 .
  • information could include characteristics of the liquid media flowing through the first filtration assembly 206 and/or second filtration assembly 208 .
  • the information could include a fluid pressure of the liquid media inside the filtration assemblies 206 , 208 , a cell density of the liquid media, a flow rate of the liquid media, the presence of an analyte in the liquid media, or some other information.
  • a bioreactor sensor 215 could be configured to collect information relating to liquid media inside the bioreactor vessel 210 , for example, a cell density or another characteristic.
  • the controller 270 may then determine whether the first filtration system 220 and/or the second filtration system 222 is in an operable state based on at least the received information from the sensor(s) 240 , 242 .
  • the term “operable” is used to refer to a filtration system that is functioning as intended, i.e., to selectively pass liquid media containing cellular waste and a product of interest, while retaining the cells within the bioreactor vessel 210 .
  • a filtration system 220 , 222 that is not in an operable state may fail to pass a desired or expected flow rate of liquid media (i.e., indicating a clogged or fouled filter membrane), or fail to retain cells (i.e., indicating the filter has ruptured). Determining whether the filtration system 220 , 222 is in an operable state could include determining whether the received information falls within an expected range of values, or falls above or below a predetermined threshold value.
  • the first filtration system 220 may have ruptured, thereby allowing cells to breach the first filtration system 220 and collect on the guard filter 250 .
  • the controller 270 may then receive information from the sensor 240 indicating an increased pressure in the liquid media caused by cells clogging the guard filter 250 . Determining whether the first filtration system 220 is in an operable state could then include determining whether a pressure in the first filtration assembly 206 (i.e., a pressure of liquid media inside the first filtration assembly 206 ) is greater than a threshold value.
  • one or more of the sensors 240 could include an optical sensor (e.g., an optical density probe) and determining whether the filtration system is in an operable state could include determining that a cell density of the liquid media inside the first filtration assembly 206 is above a threshold level, indicating that cells have breached the first filtration system 220 .
  • the bioreactor sensor 215 could be an optical sensor, and determining whether the filtration systems 220 , 222 are in an operable state could include determining that a cell density of the liquid media inside the bioreactor vessel 210 is under a threshold level.
  • the first filtration system 220 may be rendered inoperable due to a failure of a first tangential flow pump and/or fouling of the filter membrane (e.g., in cases where the first filtration system 220 is an ATF or other tangential flow-based filter). In such a situation, cells may build up on the filter membrane, preventing or diminishing the flow of liquid media through the first filtration system 220 .
  • the sensor 240 could be configured to measure a transmembrane pressure across the first filtration system 220 . Determining whether the first filtration system 220 is in an operable state could include determining that the transmembrane pressure across the filtration system 220 is above a threshold value.
  • the senor 240 could include a flow meter and determining whether the first filtration system 220 is in an operable state could include determining that flow of liquid media through the first filtration system 220 (and/or the first filtration assembly 206 ) is below a threshold level.
  • Other failure modes, sensor parameters, and determinants may be envisioned by one of ordinary skill in the art.
  • the automated response system i.e., controller 270
  • the automated response system may function to sequester the malfunctioning filtration assembly 206 , 208 by preventing liquid media from flowing through the affected filtration system 220 , 222 .
  • the controller 270 may cause the first harvest pump 230 to stop pumping liquid media through the first filtration system 220 by e.g., cutting off power to the harvest pump 230 .
  • the controller 270 could further be configured to shut down the first filtration system 220 by causing a tangential flow pump of the filtration system 220 to stop pumping liquid media across the filter membrane (i.e., in cases where the filtration system 220 includes an ATF). In other examples, the controller 270 could be configured to divert the liquid media to a waste collection system by actuating a waste valve connected in series with the first filtration system 220 or the second filtration system 222 .
  • the controller 270 may completely shut down flows in and out of the bioreactor vessel 210 if information from a bioreactor sensor 215 (e.g., a capacitance, optical density, oxygen uptake rate, or other aspect of liquid media inside the bioreactor vessel 210 ) drops above or below a certain threshold.
  • a bioreactor sensor 215 e.g., a capacitance, optical density, oxygen uptake rate, or other aspect of liquid media inside the bioreactor vessel 210 .
  • the first filtration assembly 206 could include a first isolation valve 265 or valves connected in series with the first filtration system 220 .
  • the first isolation valve 265 could be configured to control the flow of liquid media through the first filtration system 220 . Responsive to a determination that the first filtration system 220 is not in an operable state, the controller 270 could be operable to close the first isolation valve 265 .
  • a second isolation valve 267 may further be connected in series with the second filtration system 222 and configured to control the flow of liquid media through the second filtration system 222 . As shown in FIG.
  • the isolation valve(s) 265 , 267 could be connected in series between the first filtration assembly 206 and/or the second filtration assembly 208 and the continuous capture operation 260 .
  • such an isolation valve or valves 265 , 267 could be located anywhere before, after, or within the first filtration assembly 206 or the second filtration assembly 208 .
  • the first isolation valve 265 and/or second isolation valve 267 could be positioned between the bioreactor vessel 210 and a respective filtration assembly 206 208 , located downstream of the filtration system(s) 220 , 222 , located downstream of the guard filter(s) 250 , 252 , or connected to an inlet of the continuous capture operation 260 .
  • the isolation valve(s) 265 , 267 may be actuated to prevent flow of liquid media and cellular products through the affected filtration system 220 , 222 , thereby preventing cells and contaminants from reaching the continuous capture operation 260 and facilitating replacement of any compromised equipment.
  • the controller 270 could also be operable to change various operating parameters of the cell culture apparatus 200 following a filter failure. As described earlier, a steady flow rate of liquid media should be supplied to the bioreactor vessel 210 and an approximately equal flow rate of waste-containing spent media may be continuously removed to promote the proliferation of cells within the bioreactor vessel 210 . Following detection of a failure in the first filtration system 220 , the controller 270 may be additionally configured to increase a flow rate of liquid media through a remaining operable second filtration system 222 such that a steady perfusion of liquid media is maintained in the bioreactor vessel 210 .
  • the increased flow rate through the remaining operable filtration system should be approximately equal to the total pre-failure flow rate through the original filtration system(s) 220 , 222 (e.g., the sum of the first flow rate through the first filtration system 220 and the second flow rate through the second filtration system 222 ).
  • the controller 240 could be operable to cause the second harvest pump 232 to increase a flow rate of liquid media through the second filtration system 242 responsive to a determination that the first filtration system 220 is not in an operable state.
  • causing the second harvest pump 232 to increase the flow of liquid media through the second filtration system 242 could include approximately doubling the flow rate.
  • the cell culture apparatus 200 could include a plurality of filtration assemblies (i.e., at least a first filtration assembly 206 and a second filtration assembly 208 ) connected in parallel and operating simultaneously.
  • the cell culture apparatus 200 may include three, four, six, or more filtration assemblies in order to achieve a desired perfusion rate.
  • the controller 270 may be operable to adjust the flow rate through any number of remaining operable filter assemblies to maintain steady perfusion of liquid media in the system. For example, responsive to determining that a first filtration system 220 is not in an operable state, the controller 270 may cause one or more harvest pumps associated with one or more further filtration assemblies to increase a flow rate of liquid media through their respective filtration systems.
  • the controller 270 may be configured to output a notification.
  • a notification could include a visual alert, for example, a blinking light, a colored light, a visual message, textual or graphical information on a display.
  • the notification could include an auditory alert, such as an alarm sound, a beeping, a ringing, an auditory message, or some other auditory component.
  • the notification could include a text message, a phone call, or an e-mail sent to a recipient associated with the cell culture apparatus.
  • FIG. 3 illustrates a cell culture apparatus 300 including dual filtration systems 320 , 322 that converge on a shared sensor 340 , guard filter 350 , and capture operation 360 .
  • the first filtration system 320 is connected in series with a first harvest pump 330
  • the second filtration system 322 is connected in series with a second harvest pump 332 .
  • Such a configuration may allow for detection of an overall failure of the cell culture apparatus 300 by way of the sensor 350 .
  • an automated response system could function to e.g., alert an operator of the cell culture apparatus 300 by outputting a notification, divert the liquid media to a waste collection system, or stop the continuous capture operation. Other automated responses are contemplated.
  • the bioreactor vessel 310 , first and second filtration systems 320 , 322 , first and second harvest pumps 330 , 332 , sensor 340 , guard filter 350 , and capture operation 360 shown in FIG. 3 may be similarly configured to the corresponding components described above in relation to FIG. 2 .
  • FIG. 4 illustrates an example of such a cell culture apparatus 400 .
  • a bioreactor vessel 410 is in fluid communication with a capture operation 460 by way of a single filtration system 420 , harvest pump 430 , sensor 440 , and guard filter 450 .
  • a controller 470 may be communicatively coupled to at least the sensor 440 and the harvest pump 430 .
  • a filter malfunction e.g., a rupture, a clog, or another defect of the filtration system 420
  • the controller 470 could be operable to cause the capture operation 460 to stop collecting product from the liquid media.
  • one or more filtration assembly could include a waste valve 485 connected in series with the filtration system 420 .
  • the waste valve 485 may be configured to divert the flow of liquid media to a waste collection system 480 .
  • the waste valve 485 could be a three-way valve, however in other examples the waste valve 485 could include one or more two-way valves.
  • Such a waste valve 485 may preferably be connected downstream of the harvest pump 430 and upstream of the guard filter 450 , however a variety of locations could be envisioned. Responsive to a determination that the filtration system 420 is not in an operable state, the controller 470 could be configured to open the waste valve 485 , thereby diverting the liquid media to waste.
  • a sensor e.g., sensor 440 or a further bioreactor sensor
  • a sensor may be configured to interact with liquid media inside the bioreactor vessel 410 and/or monitor cell density in the vessel 410 .
  • the controller 470 could be configured to stop perfusion altogether by e.g., closing the waste valve 485 , closing an isolation valve, causing one or more harvest pumps 420 to stop pumping liquid media through one or more filtration systems 420 , or by some other means.
  • the bioreactor vessel 410 , filtration system 420 , harvest pump 430 , sensor 440 , guard filter 450 , capture operation 460 , and controller 470 shown in FIG. 4 may be similarly configured to the corresponding components described above in relation to FIG. 2 .
  • FIG. 5 is a flowchart of a method 500 for operating a cell culture apparatus, such as any of the apparatuses shown in FIG. 2, 3 , or 4 and described herein.
  • the cell culture apparatus operated in method 500 includes: (i) a bioreactor vessel; (ii) a first filtration system in fluid communication with the bioreactor vessel; (ii) a second filtration system in fluid communication with the bioreactor vessel; (iii) a first harvest pump connected in series with the first filtration system; (iv) a second harvest pump connected in series with the second filtration system; and (v) a sensor configured to interact with liquid media flowed through at least the first filtration system.
  • Block 501 of method 500 includes at least partially filling a bioreactor vessel with cells and liquid media.
  • the bioreactor vessel is in fluid communication with a first filtration system and a second filtration system connected in parallel with the first filtration system.
  • At least partially filling a bioreactor vessel with cells and liquid media could include providing cells as a monolayer on an artificial substrate (i.e., an adherent culture)
  • at least partially filling a bioreactor vessel with cells and liquid media could include providing cells free-floating in the media (i.e., as a suspension culture).
  • Liquid media for continuous perfusion may be provided by a feed operation configured to continuously introduce fresh liquid media into the bioreactor vessel.
  • Liquid media from the feed operation may be provided at a predetermined flow rate tailored to the nutritional needs of the cells within the bioreactor vessel.
  • Block 502 of method 500 includes pumping liquid media from the bioreactor vessel through the first filtration system using a first harvest pump.
  • Block 503 of method 500 includes pumping liquid media from the bioreactor vessel through the second filtration system using a second harvest pump.
  • the first harvest pump could be connected in series with the first tangential flow.
  • the second harvest pump may be connected in series with the second filtration system.
  • Pumping liquid media through the first filtration system could include pumping liquid media at a first flow rate.
  • Pumping liquid media through the second tangential flow rate could include pumping liquid media at a second flow rate.
  • the first flow rate may be substantially equal to the second flow rate under normal operating conditions.
  • the flow rate of liquid media through the first filtration system may be different than the flow rate of liquid media through the second filtration system.
  • the sum of the first flow rate and the second flow rate could be approximately equal to a flow rate of media into the bioreactor vessel by a feed operation (e.g., the feed operation described previously in relation to block 501 of method 500 ).
  • Block 504 of method 500 includes receiving, from a sensor configured to interact with liquid media flowed through at least the first filtration system, information indicative of an operational state of the first filtration system.
  • a sensor may be located within a filtration assembly that includes the first filtration system, the first harvest pump and/or other elements. Additionally or alternatively, the sensor could be disposed within a conduit connected in series with the first filtration system and/or the first harvest pump.
  • the senor is a pressure sensor (e.g., a piezoresistive pressure sensor).
  • Information indicative of an operational state of the first filtration system could include information relating to a pressure in liquid media flowing through the first filtration system. More specifically, the information could include a pressure in the liquid media upstream of the first filtration system, a pressure in the liquid media downstream of the first filtration system, or a differential transmembrane pressure in the liquid media across the first filtration system.
  • the cell culture apparatus includes a guard filter connected in series with the first filtration system downstream of the first filtration system. In such an example, the information could include a pressure in the liquid media upstream of the guard filter.
  • the senor could include a capacitance sensor, a Raman probe, an FTIR probe, or an optical density probe.
  • the information could include information relating to a cell density of cells in the liquid media (e.g., the liquid media downstream of the first filtration system).
  • Block 505 of method 500 includes determining, based on at least the received information, whether the first filtration system is in an operable state.
  • the filter may pass a desired or expected flow rate of liquid media (i.e., indicating a clogged or fouled filter membrane), or fail to retain cells (i.e., indicating the filter has ruptured).
  • Determining whether the filtration system is in an operable state could include determining whether the information received from the sensor falls within an expected range of values, or falls above or below a predetermined threshold value.
  • the sensor is a pressure sensor, and determining whether the first filtration system is in an operable state includes determining that a pressure of the liquid media is above a predetermined threshold value.
  • determining whether the first filtration system is in an operable state could include determining that a transmembrane pressure across the first filtration system is above a predetermined threshold value. In still further examples, determining whether the first filtration system is in an operable state could include determining that a cell density of the liquid media (e.g., the liquid media in the bioreactor vessel, or liquid media flowing through the first filtration system) is outside of a predetermined threshold range.
  • Block 506 of method 500 includes, responsive to a determination that the first filtration system is not in an operable state, causing the first harvest pump to stop pumping liquid media through the first filtration system. Such a response may effectively stop the flow of liquid media through the first filtration system.
  • an isolation valve may be connected in series with the first filtration system and configured to control the flow of liquid media through the first filtration system.
  • method 500 could include, responsive to a determination that the first filtration system is not in an operable state, closing the isolation valve. Other responses to a malfunctioning filter are also anticipated.
  • method 500 could further include adjusting a flow rate of one or more remaining operable filters.
  • the method 500 may further include causing the second harvest pump to increase a flow rate of liquid media through the second filtration system responsive to a determination that the first filtration system is not in an operable state. Increasing the flow rate of liquid media through the second filtration system could allow perfusion of liquid media through the bioreactor vessel to continue at steady rate following a filter failure. In other words, the adjusted flow rate of liquid media through the second filtration system may be approximately equal to the flow rate of liquid media through an operable first and second filtration system.
  • causing the second harvest pump to increase a flow rate of liquid media through the second filtration system could include approximately doubling the flow rate of liquid media through the second filtration system.
  • method 500 further includes outputting a notification responsive to a determination that the first filtration system is not in an operable state.
  • the notification may comprise a visual alert (e.g., a blinking light, a colored light, a visual message, textual or graphical information on a display) and/or an auditory alert (e.g., an alarm sound, a beeping, a ringing, an auditory message, or some other auditory component).
  • method 500 could include diverting liquid media to waste collection system, stopping a downstream capture operation, or affecting other aspects of the operation of a cell culture apparatus.
  • the exemplary method 500 illustrated in FIG. 5 is meant as an illustrative, non-limiting example. Blocks and steps described herein may be carried out sequentially or in parallel. Furthermore, the various block and steps could be carried out in a different order than described herein and some blocks and steps could be omitted, skipped, and/or repeated. Additional or alternative elements of the method and additional or alternative components of the systems are contemplated.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Computer Hardware Design (AREA)
  • Molecular Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
US16/403,161 2018-05-04 2019-05-03 Perfusion Bioreactor With Filtration Systems Abandoned US20190338238A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US16/403,161 US20190338238A1 (en) 2018-05-04 2019-05-03 Perfusion Bioreactor With Filtration Systems
US17/524,269 US11434464B2 (en) 2018-05-04 2021-11-11 Perfusion bioreactor with filtration systems
US18/308,870 US12110483B2 (en) 2018-05-04 2023-04-28 Perfusion bioreactor with filtration systems
US18/823,894 US20250027031A1 (en) 2018-05-04 2024-09-04 Perfusion Bioreactor With Filtration Systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862667319P 2018-05-04 2018-05-04
US16/403,161 US20190338238A1 (en) 2018-05-04 2019-05-03 Perfusion Bioreactor With Filtration Systems

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US17/524,269 Continuation US11434464B2 (en) 2018-05-04 2021-11-11 Perfusion bioreactor with filtration systems
US18/308,870 Continuation US12110483B2 (en) 2018-05-04 2023-04-28 Perfusion bioreactor with filtration systems

Publications (1)

Publication Number Publication Date
US20190338238A1 true US20190338238A1 (en) 2019-11-07

Family

ID=66554504

Family Applications (4)

Application Number Title Priority Date Filing Date
US16/403,161 Abandoned US20190338238A1 (en) 2018-05-04 2019-05-03 Perfusion Bioreactor With Filtration Systems
US17/524,269 Active US11434464B2 (en) 2018-05-04 2021-11-11 Perfusion bioreactor with filtration systems
US18/308,870 Active US12110483B2 (en) 2018-05-04 2023-04-28 Perfusion bioreactor with filtration systems
US18/823,894 Pending US20250027031A1 (en) 2018-05-04 2024-09-04 Perfusion Bioreactor With Filtration Systems

Family Applications After (3)

Application Number Title Priority Date Filing Date
US17/524,269 Active US11434464B2 (en) 2018-05-04 2021-11-11 Perfusion bioreactor with filtration systems
US18/308,870 Active US12110483B2 (en) 2018-05-04 2023-04-28 Perfusion bioreactor with filtration systems
US18/823,894 Pending US20250027031A1 (en) 2018-05-04 2024-09-04 Perfusion Bioreactor With Filtration Systems

Country Status (12)

Country Link
US (4) US20190338238A1 (zh)
EP (1) EP3788131A1 (zh)
JP (3) JP7328256B2 (zh)
KR (2) KR20250021651A (zh)
CN (3) CN118344950A (zh)
AU (2) AU2019262624B2 (zh)
CA (1) CA3099135A1 (zh)
IL (2) IL317267A (zh)
MX (3) MX2020011729A (zh)
SG (1) SG11202010883QA (zh)
TW (2) TWI898645B (zh)
WO (1) WO2019213567A1 (zh)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210025871A1 (en) * 2019-07-25 2021-01-28 Csem Centre Suisse D'electronique Et De Microtechnique Sa - Recherche Et Developpement Purification process for cells
US11434464B2 (en) * 2018-05-04 2022-09-06 Genzyme Corporation Perfusion bioreactor with filtration systems
WO2022229381A1 (en) * 2021-04-29 2022-11-03 Univercells Technologies Sa Systems and methods for the continuous production and purification of biologics
WO2023287707A1 (en) 2021-07-15 2023-01-19 Just-Evotec Biologics, Inc. Bidirectional tangential flow filtration (tff) perfusion system
US11673083B2 (en) 2021-04-16 2023-06-13 Repligen Corporation Filtration system with selective flow reversal
WO2023154245A2 (en) 2022-02-10 2023-08-17 Just-Evotec Biologics, Inc. Depth filter and viral filter (df/vf) cart for batch and continuous processing
WO2025147484A1 (en) * 2024-01-04 2025-07-10 Wainamics, Inc. Microfluidic biospecimen cartridge

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022500242A (ja) * 2018-09-21 2022-01-04 サイティバ・スウェーデン・アクチボラグ 灌流バイオプロセシングシステムおよびそれを動作させる方法
CN113699042B (zh) * 2021-08-17 2022-07-22 华艾博越(上海)生物医疗科技有限公司 细胞培养箱的控制系统
WO2023033299A1 (ko) * 2021-09-02 2023-03-09 주식회사 엠디뮨 세포 유래 소포체 제조 장치 및 이를 이용한 제조 방법
US20250027024A1 (en) * 2021-12-15 2025-01-23 Celltrio, Inc. Media liquid supply apparatus
US20230211265A1 (en) * 2021-12-31 2023-07-06 Pall Corporation Bulk fill system with serial fluid filtration assembly and method of using same for automated air transfer
WO2023229971A1 (en) * 2022-05-25 2023-11-30 Repligen Corporation Recovery of perfusion bleed product via alternating tangential flow filtration in a sedimentation reactor
US12157873B2 (en) 2022-09-28 2024-12-03 Genzyme Corporation Systems and devices for producing biological products and methods of using the same
WO2024080892A2 (en) * 2022-10-11 2024-04-18 Limited Liability Company "Biotechno" Perfusion filtration system for continuous cultivation of cell cultures
WO2024122708A1 (ko) * 2022-12-07 2024-06-13 주식회사 팡세 생물반응기 시스템 및 이를 이용한 세포 배양방법
WO2024122714A1 (ko) * 2022-12-07 2024-06-13 주식회사 팡세 투석장치 및 이를 포함하는 생물반응기 시스템

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017040696A1 (en) * 2015-08-31 2017-03-09 Porifera, Inc. Water purification systems and methods having pressurized draw stream
US20180127705A1 (en) * 2016-11-07 2018-05-10 Deka Products Limited Partnership System and Method for Creating Tissue

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974068A (en) 1971-11-26 1976-08-10 Firma Heinrich Frings Ultrafiltration process and apparatus using low hydrostatic pressure to prevent concentration polarization
DE2254860C3 (de) * 1971-11-26 1984-03-29 Heinrich Frings Gmbh & Co Kg, 5300 Bonn Ultrafiltrationsverfahren für Flüssigkeiten, die Mikroorganismen, Makromoleküle oder andere kleine Feststoffteilchen enthalten
JPH0621728A (ja) 1992-07-06 1994-01-28 Sharp Corp 出力増幅器用電源回路
JPH0621728U (ja) * 1992-08-26 1994-03-22 水道機工株式会社 透過膜によるろ過装置
JP3028447B2 (ja) * 1993-05-12 2000-04-04 住友重機械工業株式会社 浄水処理装置
JP3401541B2 (ja) * 1993-08-27 2003-04-28 栗田工業株式会社 膜分離装置及びその運転方法
US5470464A (en) * 1994-04-06 1995-11-28 Uop Small scale simulated moving bed separation apparatus and process
US5947689A (en) * 1997-05-07 1999-09-07 Scilog, Inc. Automated, quantitative, system for filtration of liquids having a pump controller
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US7270744B2 (en) * 2001-10-09 2007-09-18 Millipore Corporation Automated low-volume tangential flow filtration process development device
US20050026134A1 (en) * 2002-04-10 2005-02-03 Bioprocessors Corp. Systems and methods for control of pH and other reactor environment conditions
EP1499705A2 (en) * 2002-05-01 2005-01-26 Massachusetts Institute of Technology Microfermentors for rapid screening and analysis of biochemical processes
AU2003238273A1 (en) * 2003-06-17 2005-02-04 Centocor, Inc. Method and apparatus for filtration of bioreactor recombinant proteins
PL1756263T3 (pl) 2004-06-14 2008-06-30 Probiogen Ag Reaktor z ekspozycją w fazie ciekłej i gazowej do hodowli komórek
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
EP1807101B1 (en) * 2004-09-30 2016-04-13 Bayer Healthcare LLC Devices and methods for integrated continuous manufacturing of biological molecules
JP2007117904A (ja) * 2005-10-28 2007-05-17 Hitachi Ltd 膜ろ過処理装置
US9109193B2 (en) * 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
US9677038B2 (en) * 2010-06-23 2017-06-13 Strobbe Pharma Tech Gmbh Device and method for industrial cultivation of cells
KR101990651B1 (ko) * 2010-08-25 2019-06-18 제리 쉐비츠 유체 여과 시스템
CN103154233A (zh) * 2010-10-05 2013-06-12 诺沃—诺迪斯克保健股份有限公司 生产蛋白质的方法
JP2012161288A (ja) * 2011-02-08 2012-08-30 Toray Ind Inc 化学品の製造装置および化学品の製造方法
SG192611A1 (en) * 2011-02-10 2013-09-30 Crucell Holland Bv Pneumatic alternating pressure membrane cell separation system
BR112014031842B1 (pt) * 2012-06-21 2020-09-15 Baxalta GmbH Método para remover um contaminante viral de uma preparação
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US10711238B2 (en) * 2012-10-02 2020-07-14 Repligen Corporation Method for proliferation of cells within a bioreactor using a disposable pumphead and filter assembly
US20140093952A1 (en) * 2012-10-02 2014-04-03 David Serway Bioreactor Tangential Flow Perfusion Filter System
AU2014228275B2 (en) * 2013-03-15 2019-03-14 Genzyme Corporation High-density cell banking methods
MY178470A (en) * 2013-06-21 2020-10-14 Toray Industries Filter device, manufacturing device for chemical, and operation method for filter device
BR112016005545B1 (pt) * 2013-09-16 2021-06-01 Genzyme Corporation Método de processamento de uma cultura de células de mamífero
CN103731853B (zh) * 2014-01-17 2017-01-04 上海触乐信息科技有限公司 双卡移动通讯设备的云识别方法、设备和系统
US20170173537A1 (en) * 2014-03-07 2017-06-22 Agency For Science, Technology And Research Apparatus and methods for fractionation of biological products
US10279316B2 (en) * 2014-05-08 2019-05-07 Thetis Environmental Inc. Closed loop membrane filtration system and filtration device
SG10202008789QA (en) * 2014-05-13 2020-10-29 Amgen Inc Process control systems and methods for use with filters and filtration processes
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
US10512888B2 (en) * 2014-06-24 2019-12-24 Parker-Hannifin Corporation Multiple identification point automated parameter assurance method
US20170213498A1 (en) 2014-07-23 2017-07-27 What Watch Ag A device with an art showing function
US20170292104A1 (en) 2014-09-17 2017-10-12 Massachusetts Institute Of Technology Microfluidic system and method for perfusion bioreactor cell retention
US9550972B2 (en) * 2014-09-29 2017-01-24 General Electric Company Devices, systems and methods for automated cell culturing
US20180030398A1 (en) * 2015-02-09 2018-02-01 Univercells Nv System, apparatus and method for the production of cells and/or cell products
TWI819383B (zh) * 2015-04-22 2023-10-21 美商伯克利之光生命科技公司 微流體器件及在該微流體器件中培養生物細胞之方法
AU2016331926B2 (en) * 2015-10-01 2021-12-09 Berkeley Lights, Inc. Well-plate incubator
WO2018015386A1 (en) * 2016-07-19 2018-01-25 The Automation Partnership (Cambridge) Limited Reversible liquid filtration system
AU2017313042A1 (en) * 2016-08-16 2019-04-04 Genzyme Corporation Methods of processing a fluid including a recombinant therapeutic protein and use thereof
CN206014947U (zh) * 2016-09-01 2017-03-15 奥凯（苏州）生物技术有限公司 一种细胞培养的自动化收集系统
TWI675696B (zh) * 2017-06-01 2019-11-01 美商Ｅｍｄ密理博公司 用於灌注應用之切向流過濾裝置
TWI898645B (zh) * 2018-05-04 2025-09-21 美商健臻公司 灌注式細胞培養裝置

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017040696A1 (en) * 2015-08-31 2017-03-09 Porifera, Inc. Water purification systems and methods having pressurized draw stream
US20180127705A1 (en) * 2016-11-07 2018-05-10 Deka Products Limited Partnership System and Method for Creating Tissue

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11434464B2 (en) * 2018-05-04 2022-09-06 Genzyme Corporation Perfusion bioreactor with filtration systems
US12110483B2 (en) 2018-05-04 2024-10-08 Genzyme Corporation Perfusion bioreactor with filtration systems
US20210025871A1 (en) * 2019-07-25 2021-01-28 Csem Centre Suisse D'electronique Et De Microtechnique Sa - Recherche Et Developpement Purification process for cells
US11673083B2 (en) 2021-04-16 2023-06-13 Repligen Corporation Filtration system with selective flow reversal
US12427454B2 (en) 2021-04-16 2025-09-30 Repligen Corporation Filtration system and method for synchronizing permeate and retentate flow
WO2022229381A1 (en) * 2021-04-29 2022-11-03 Univercells Technologies Sa Systems and methods for the continuous production and purification of biologics
WO2023287707A1 (en) 2021-07-15 2023-01-19 Just-Evotec Biologics, Inc. Bidirectional tangential flow filtration (tff) perfusion system
WO2023154245A2 (en) 2022-02-10 2023-08-17 Just-Evotec Biologics, Inc. Depth filter and viral filter (df/vf) cart for batch and continuous processing
WO2025147484A1 (en) * 2024-01-04 2025-07-10 Wainamics, Inc. Microfluidic biospecimen cartridge

Also Published As

Publication number Publication date
IL278414B1 (en) 2025-01-01
IL317267A (en) 2025-01-01
BR112020022399A2 (pt) 2021-02-02
TW202003832A (zh) 2020-01-16
KR20250021651A (ko) 2025-02-13
CN112313323B (zh) 2024-03-29
NZ770626A (en) 2025-05-02
US20250027031A1 (en) 2025-01-23
TWI846694B (zh) 2024-07-01
US20220073861A1 (en) 2022-03-10
US20230340396A1 (en) 2023-10-26
MX2020011729A (es) 2021-04-12
CN118344951A (zh) 2024-07-16
IL278414B2 (en) 2025-05-01
CN118344950A (zh) 2024-07-16
JP2023145667A (ja) 2023-10-11
EP3788131A1 (en) 2021-03-10
AU2024227766A1 (en) 2024-11-21
KR102764204B1 (ko) 2025-02-07
JP2025060872A (ja) 2025-04-10
TW202505016A (zh) 2025-02-01
WO2019213567A1 (en) 2019-11-07
AU2019262624B2 (en) 2024-08-01
KR20210005237A (ko) 2021-01-13
AU2019262624A1 (en) 2021-01-07
CN112313323A (zh) 2021-02-02
SG11202010883QA (en) 2020-11-27
JP2021522794A (ja) 2021-09-02
JP7614266B2 (ja) 2025-01-15
US11434464B2 (en) 2022-09-06
IL278414A (zh) 2020-12-31
US12110483B2 (en) 2024-10-08
TWI898645B (zh) 2025-09-21
MX2025002747A (es) 2025-04-02
JP7328256B2 (ja) 2023-08-16
CA3099135A1 (en) 2019-11-07
MX2025002769A (es) 2025-04-02

Similar Documents

Publication Publication Date Title
US12110483B2 (en) Perfusion bioreactor with filtration systems
US10836663B2 (en) Wastewater treatment with modular membrane bioreactor cartridges
KR102567418B1 (ko) 세포 배양 시스템 및 세포 배양 방법
RU2795881C2 (ru) Перфузионный биореактор с системами фильтрации
BR122025010449A2 (pt) Dispositivo de cultivo de células de perfusão e método de cultivo de células
BR122023023944A2 (pt) Dispositivo de cultivo de células de perfusão compreendendo biorreator de perfusão com sistemas de filtração
BR122023023944B1 (pt) Dispositivo de cultivo de células de perfusão compreendendo biorreator de perfusão com sistemas de filtração
BR112020022399B1 (pt) Dispositivo de cultivo de células de perfusão compreendendo biorreator de perfusão com sistemas de filtração e método de cultivo de células
JP3560708B2 (ja) 膜分離装置、そのリーク検出方法およびその運転方法
JP2014024824A (ja) 潅流培養における有用タンパク質を含む培養液の濾過方法
US20250223209A1 (en) Water treatment system with biocontactor
RU2020139625A (ru) Перфузионный биореактор с системами фильтрации

Legal Events

Date Code Title Description
AS Assignment

Owner name: GENZYME CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LU, JIUYI;WALTHER, JASON;WANG, JONATHAN;AND OTHERS;SIGNING DATES FROM 20190425 TO 20190426;REEL/FRAME:050623/0132

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION